Dr. L. Belmans SPRL
Dr. L. Belmans reported total assets of €2.68m at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).
By total assets for 2025, Dr. L. Belmans ranks among the 500 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr. L. Belmans shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +13 % Total assets +3 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. L. Belmans's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 24 Jul 2024
- Year ended 31 Dec 2022filed on 25 Jul 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Dr. L. Belmans's financial analysis
- Solvency77.5%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. L. Belmans
Dr. L. Belmans's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0463.984.454
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 12 Aug 1998
- Registered office
- 2440 Geel
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. L. Belmans (SPRL) has been based in Geel since 1998, active in: medical specialists activities. For 2025, it reports a net profit of 231,518 € and equity of €2.08m; its revenue is not published. Its solvency stands at 77.5%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. L. Belmans
Companies in the same business, of comparable size and area, outside its group.
- Opdeeco Sint-Niklaas · balance sheet €2.68m
- Quesnoy Anzegem · balance sheet €2.68m
- Pradel Nandrin · balance sheet €2.69m
- B & T Invest Warehousing and storage Kontich · balance sheet €2.69m
- Codemi Sprimont · balance sheet €2.67m
- Greenovate Deinze · balance sheet €2.68m
- Dr. VRIJDAG MARC Londerzeel · balance sheet €2.69m
- Estheda Bekkevoort · balance sheet €2.68m
Frequently asked questions about Dr. L. Belmans
What is the revenue of Dr. L. Belmans?
Dr. L. Belmans files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. L. Belmans?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Dr. L. Belmans. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0463984454. Its company number (CBE) is 0463.984.454.
Where is the registered office of Dr. L. Belmans?
According to the CBE register, the registered office of Dr. L. Belmans is in 2440 Geel.
What is the equity of Dr. L. Belmans?
At the close of the 2025 financial year, the equity of Dr. L. Belmans amounts to 2,078,113 €, a solvency of 77.5% of total assets.
Who manages Dr. L. Belmans?
The register lists 1 active mandates at Dr. L. Belmans. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr. L. Belmans within its sector?
By total assets for 2025, Dr. L. Belmans ranks among the 500 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Dr. L. Belmans
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →